Ferritin Testing Market Surpass US$ 556.19 million by 2027 Says, The Insight Partners

The ferritin testing market was valued at US$ 372.05 million in 2019 and is projected to reach US$ 556.19 million by 2027; it is expected to grow at a CAGR of 5.3% from 2020 to 2027.

The increasing prevalence of anemia, aging population, and malnutrition is driving the demand for ferritin testing globally to measure the level of iron in blood. The adoption of ferritin testing services has grown at an unprecedented rate in last few years owing to growing incidences of iron deficiency disorders and increasing prevalence of iron deficiency in aging population. Moreover, government initiatives to reduce anemia worldwide is expected to foster the market growth during the forecast period. However, the availability of advanced technologies is restricting the market growth.

Get sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00008620/?utm_source=OpenPR&utm_medium=10144

Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., bioMérieux SA, Doctorcall, Aviva Systems Biology Corporation, Biopanda Reagents Ltd, Monobind Inc., Orgentec Diagnostika, Thermo Fisher Scientific Inc, and Sekisui Diagnostic are among the leading companies operating in the global ferritin testing market.

The unparalleled global crisis triggered by the COVID-19 pandemic poses serious risks to the nutritional status and survival of young children in the South American countries. There is an expected increase in child malnutrition due to steep declines in household incomes, interruptions to health, nutrition, and social protection services. Therefore, the pandemic situation has negatively impacted the ferritin testing market in South and Central America.

Get the Latest COVID-19 Analysis on this market at: https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00008620?utm_source=OpenPR&utm_medium=10144

Based on indication, the ferritin testing market is segmented into anemia, hemochromatosis, pregnancy, and lead poisoning. The anemia segment held the largest share of the market in 2019. The growth is ascribed to the rising malnutrition in developing countries, aging population, changing dietary habits, and lack of awareness regarding iron deficiency.

In North America, the US is profoundly affected by the outbreak of COVID-19. The country has marked the highest number of positive cases. Across the nation, various healthcare research centers are working on COVID-19 therapeutics. Additionally, during the initial phase of COVID-19 crisis, lockdowns and supply chain disruptions negatively impacted the demand for ferritin testing.

For instance, the American Academy of Pediatrics has recommended universal screening for iron deficiency at 12 months. The WHO also suggests an assessment of ferritin and soluble transferrin receptor levels during pregnancy and early childhood. Measurement of ferritin aids in the diagnosis of iron metabolism. Furthermore, technological developments are expected to propel the growth of the market. For instance, in 2019, Eurolyser Diagnostica GmbH added a new feature to its product Cube, which is used for testing iron deficiency. Therefore, increasing prevalence of iron deficiency and government regulations to reduce anemia are expected to fuel the growth of the ferritin testing market.

Iron is an essential dietary mineral required for various functions, including the transport of oxygen in the blood. Iron is also vital for brain development. Infants, children, and teenagers undergo rapid growth changes, which increase their need for iron. Iron is the most common nutritional deficiency among infants, children, and pregnant women and is associated with long-term detrimental effects on neurodevelopment. As per the World Health Organization (WHO), nearly 42% of children less than five years of age and 40% of pregnant women worldwide are anemic. Poor nutritional habits, increased blood loss during , and increased blood-supply demands during pregnancy contribute to the increased prevalence of anemia in women. Apart from this, hemoglobinopathies and infectious diseases such as malaria, tuberculosis, and parasitic infections cause anemia. To reduce the burden of anemia in infants, many government organizations have recommended screening for iron deficiency, which is driving the ferritin market.

Order a Copy of Ferritin Testing Market Shares, Strategies and Forecasts 2021-2028 Research Report at: https://www.theinsightpartners.com/buy/TIPRE00008620/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

This release was published on openPR.